Literature DB >> 14621774

Liver transplantation in hepatocellular carcinoma.

E Jaurrieta1, J Fabregat, J Figueras, R Bella, P Moreno-Llorente, A Rafecas, J Torras, T Casanovas, L Casais.   

Abstract

The initial enthusiasm for orthotopic liver transplantation (OLT) in patients with hepatocellular carcinoma (HCC) soon vanished as early recurrences appeared. OLT in HCC remains a controversial issue. We evaluated the efficacy of preoperative studies to select No-Mo patients and determined whether pT stage and histopathological grade (G) have a prognostic significance. A group of 25 patients, all previously thoroughly studied to rule out extrahepatic disease, underwent OLT for HCC. All patients were pNo after pathological study and none of the six patients who died in the postoperative period showed extrahepatic dissemination at necropsy (pMo). The recurrence rate was 43%. The 2 and 5 years actuarial survival was 62% and 43% respectively. The pT and G were not prognostic factors for long-term survival. We think that HCC is still a good indication for OLT because almost 50% of patients have good survival prospects.

Entities:  

Mesh:

Year:  1992        PMID: 14621774     DOI: 10.1007/978-3-642-77423-2_61

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  2 in total

1.  Current management of patients with hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Sadahisa Ogasawara; Tetsuhiro Chiba; Yuki Haga; Masao Omata; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2015-07-28

2.  Historical perspective on the importance of the Milan criteria.

Authors:  J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.